The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
e bei sha tan yu qing lv zuo zuo lian he zhi liao yuan fa xing gao xue ya de liao xiao he hu li guan cha
Author(s): 
Pages: 12-13
Year: Issue:  4
Journal: THE MEDICAL JOURNAL OF INDUSTRIAL ENTERPRISE

Keyword:  厄贝沙坦氢氯噻嗪原发性高血压护理观察;
Abstract: 目的:观察厄贝沙坦(国产)与氢氯噻嗪对1.2级原发性高血压的疗效和安全性.方法:73例1.2级原发性高血压患者随机分两组,分别服用厄贝沙坦150mg qd,与氢氯噻嗪12.5mg qd和卡托普利25mg Tid与氢氯噻嗪12.5mg qd,治疗4周.观察用药前后血压、心率变化,记录患者用药的不良反应,结合实验室检查作安全性评价.结果:治疗后与治疗前相比,两组血压下降均有非常显著性差异(P<0.01).厄贝沙坦组总有效率为80.6%,卡托普利为77.1%,两组间比较无显著性差异(P>0.05),但药物相关不良反应前者显著低于后者(2.8与17.1%,P<0.05).结论:厄贝沙坦与氢氯噻嗪联合应用治疗1.2级原发性高血压疗效确切,患者耐受性和安全性较好.仔细的护理观察是取得良好控制血压的一项重要保证.
Related Articles
No related articles found